Hormone infusion improves pancreatic insulin production in cystic fibrosis patients with or at risk for diabetes
A Penn Medicine study finds medication therapy based on the hormone glucagon-like peptide-1(GLP-1) may help regulate natural insulin production in cystic fibrosis, potentially offering a better way to prevent and ultimately manage diabetes than daily insulin injections.
FULL STORY AT Penn Medicine News →